Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Asset Utilization Ratio (2017 - 2025)

Protagonist Therapeutics' Asset Utilization Ratio history spans 9 years, with the latest figure at 0.07 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 89.44% year-over-year to 0.07; the TTM value through Dec 2025 reached 0.07, down 89.44%, while the annual FY2025 figure was 0.07, 91.73% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.07 at Protagonist Therapeutics, down from 0.29 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.64 in Q4 2024 and bottomed at 0.03 in Q4 2023.
  • The 5-year median for Asset Utilization Ratio is 0.28 (2025), against an average of 0.27.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 3733.71% in 2021 before it crashed 94.46% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.08 in 2021, then skyrocketed by 591.35% to 0.52 in 2022, then plummeted by 94.46% to 0.03 in 2023, then surged by 2087.46% to 0.64 in 2024, then plummeted by 89.44% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for PTGX's Asset Utilization Ratio are 0.07 (Q4 2025), 0.29 (Q3 2025), and 0.28 (Q2 2025).